Physician Search
 |
 |
 |
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
Multiple Cancer Types
This trial will look at a drug called SEA-TGT (also known as SGN-TGT) to find out whether it
is safe for patients with solid tumors and lymphomas. It will study SEA-TGT to find out what
its side effects are. A side effect is anything the drug does besides treating cancer. It
will also study whether SEA-TGT works to treat solid tumors and lymphomas.
The study will have three parts. Part A of the study will find out how much SEA-TGT should be
given to patients. Part B will use the dose found in Part A to find out how safe SEA-TGT is
and if it works to treat solid tumors and lymphomas. Part C will study how well SEA-TGT with
sasanlimab works to treat solid tumors.
is safe for patients with solid tumors and lymphomas. It will study SEA-TGT to find out what
its side effects are. A side effect is anything the drug does besides treating cancer. It
will also study whether SEA-TGT works to treat solid tumors and lymphomas.
The study will have three parts. Part A of the study will find out how much SEA-TGT should be
given to patients. Part B will use the dose found in Part A to find out how safe SEA-TGT is
and if it works to treat solid tumors and lymphomas. Part C will study how well SEA-TGT with
sasanlimab works to treat solid tumors.
Gastric/Gastroesophageal,
Head/Neck,
Lung,
Non Small Cell,
Ovarian,
Phase I
I
Crispens, Marta
NCT04254107
VICCPHI2125
